Results 61 to 70 of about 74,305 (343)

Successful treatment of concomitant alopecia universalis and Crohn’s disease with upadacitinib: A case report

open access: yesSAGE Open Medical Case Reports, 2023
Alopecia areata is a non-scarring, autoimmune hair loss disorder that is associated with inflammatory bowel disease. Alopecia areata and inflammatory bowel disease may have a common pathogenic mechanism that involves the Janus kinase/STAT pathway.
Leah A Johnston   +2 more
doaj   +1 more source

Hydroxychloroquine for granuloma annulare: A case report on secondary hair growth in alopecia universalis

open access: yesSAGE Open Medical Case Reports, 2023
Alopecia areata is an autoimmune disease resulting in non-scarring hair loss. Alopecia areata can progress to become alopecia totalis (loss of hair from the entire scalp) or alopecia universalis (loss of hair form the entire body), with the progression ...
Selena Osman, Danya Traboulsi
doaj   +1 more source

Hair follicle immune privilege and its collapse in alopecia areata

open access: yesExperimental Dermatology, 2020
Anagen stage hair follicles (HFs) exhibit “immune privilege (IP)” from the level of the bulge downwards to the bulb. Both passive and active IP mechanisms protect HFs from physiologically undesired immune responses and limit immune surveillance.
M. Bertolini   +4 more
semanticscholar   +1 more source

Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata

open access: yesInternational Journal of Molecular Sciences, 2021
Alopecia areata (AA) is regarded as a tissue-specific and cell-mediated autoimmune disorder. Regarding the cytokine balance, AA has been considered a type 1 inflammatory disease.
R. Kageyama   +7 more
semanticscholar   +1 more source

Severe Infliximab-Induced Alopecia and Scalp Psoriasis in a Woman with Crohn’s Disease: Dramatic Improvement after Drug Discontinuation and Treatment with Adjuvant Systemic and Topical Therapies [PDF]

open access: yes, 2016
Scalp psoriasis with alopecia is a rare cutaneous reaction to tumor necrosis factor alpha antagonists. This reaction often reverses with discontinuation of the offending drug and initiation of topical treatments; however, irreversible hair loss may occur
Jeremy Udkoff, Philip R. Cohen
core   +1 more source

Autoimmunity: Alopecia Areata [PDF]

open access: yesJournal of Investigative Dermatology Symposium Proceedings, 2004
Strong direct and indirect evidence supports an autoimmune etiology for alopecia areata. T lymphocytes that have been shown to be oligoclonal and autoreactive are predominantly present in the peribulbar inflammatory infiltrate. Alopecia areata frequently occurs in association with other autoimmune diseases, such as thyroiditis and vitiligo, and ...
Marna E. Ericson, Maria K. Hordinsky
openaire   +3 more sources

Epidemiology of alopecia areata in Baqubah city/Diyala-Iraq

open access: yesDiyala Journal of Medicine, 2023
Background: Alopecia areata is a disease scalp and body hair leading to patches of non-scoring alopecia which is heterogeyous ,it is unown as autommutte disease, there is no prevention & hard cure.
Rihab Shihab Ahmed,   +3 more
doaj   +1 more source

Immunology of alopecia areata

open access: yesCentral European Journal of Immunology, 2020
Alopecia areata is a condition that affects hair follicles and leads to hair loss ranging from small well-defined patches to complete loss of all body hair. Despite its high incidence, the pathobiology is not fully understood, and no single concept could be universally accepted. Alopecia areata is mostly considered to be an autoimmune disease, in which
Lidia Rudnicka   +2 more
openaire   +2 more sources

Evolving Real‐World Data and Evidence Use for New Drugs and Regenerative Medical Products Approvals in Japan—An Analysis of the 6‐Year Trend

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Several regulatory initiatives have been made to clarify the acceptability and requirements of real‐world data and real‐world evidence (RWD/E) for the benefit/risk assessment of new medical products in Japan. The objectives of this review were to characterize the use of RWD/E in regulatory applications of new medical products and to describe the ...
Suguru Okami   +2 more
wiley   +1 more source

Clinical and histological challenge in the differential diagnosis of diffuse alopecia: female androgenetic alopecia, telogen effluvium and alopecia areata - part II Desafio clínico e histológico no diagnóstico diferencial de alopecia difusa: alopecia androgenética, eflúvio telógeno e alopecia areata - parte II

open access: yesAnais Brasileiros de Dermatologia, 2012
Diffuse alopecia is mainly caused by telogen effluvium, diffuse androgenetic alopecia (femalepattern hair loss) and diffuse alopecia areata. Differential diagnosis between the three disorders may be difficult in several occasions.
Betina Werner, Fabiane Mulinari-Brenner
doaj   +1 more source

Home - About - Disclaimer - Privacy